# Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

> **NCT04870424** · PHASE3 · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 120 (actual)

## Conditions studied

- Transcatheter Aortic Valve Replacement
- Atrial Fibrillation New Onset
- Pacemaker
- Colchicine

## Interventions

- **DRUG:** Colchicine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04870424
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-21
- **Primary completion:** 2024-05-26
- **Final completion:** 2025-06-03
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04870424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04870424, "Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04870424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*